Bioimpedance and Hand-held Echocardiographay for Clinical Decision-making in Treatment of Cardio-renal Syndrome Type I
NCT02959281 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2019-06-28
Summary
The purpose of this study is to investigate whether hemodynamic data obtained by a noninvasive bio-impedance system (NICAS) sampled from patients with cardiorenal syndrome type I (CRS1) improve clinical outcomes. We hypothesize that hemodynamic data provided to the caring physician will improve management of CRS1 patients.
Conditions
- Cardio-Renal Syndrome
Interventions
- OTHER
-
Providing caring physicians with hemodynamic variables
NICAS electrodes are applied to the skin of the forearm bilaterally (similar to EKG electrodes). Conductors, attached to the electrodes, connect the patient with the measuring system.
Sponsors & Collaborators
-
HaEmek Medical Center, Israel
lead OTHER
Principal Investigators
-
Guy Dori, MD, DSc · haemek medical center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 40 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-06-01
- Primary Completion
- 2019-06-16
- Completion
- 2019-06-16
More Related Trials
-
Renal Effects of Intrarenal Nesiritide
NCT00270829 ·Status: TERMINATED ·Phase: PHASE4
-
Effects of Chimeric Natriuretic Peptide Versus Placebo in Stable Heart Failure and Moderate Renal Dysfunction
NCT01407900 ·Status: WITHDRAWN ·Phase: PHASE1
-
Spironolactone in Patients With Single Ventricle Heart
NCT00211081 ·Status: COMPLETED ·Phase: NA
-
Enhancing Fluid Transfer Through the Skin, by Increased Sweat Rate, on Hemodialysis Patients
NCT06358365 ·Status: COMPLETED ·Phase: NA
-
The Role of Mineralocorticoid Receptors in Vascular Function
NCT00759525 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Comparison of Oral or Intravenous Thiazides vs Tolvaptan in Diuretic Resistant Decompensated Heart Failure
NCT02606253 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Candesartan on Brain Natriuretic Peptide Levels in Subjects With Chronic Heart Failure
NCT00843154 ·Status: TERMINATED ·Phase: PHASE3
-
Low Dose Intravenous (IV) Infusion of BNP in the Presence and Absence of Acute Type V Phosphodiesterase (PDE V) in Improving Renal Function in Hospitalized Chronic Heart Failure (CHF) Patients With Renal Dysfunction
NCT00972569 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Nesiritide and Renal Function After the Total Artificial Heart
NCT01836809 ·Status: TERMINATED ·Phase: PHASE4
-
Renal Denervation for Resistant Hypertension
NCT01865240 ·Status: TERMINATED ·Phase: PHASE4
-
PREVENTION OF WORSENING RENAL FUNCTION OF INTRAVENUS ALBUMIN IN HEART FAILURE PATIENTS
NCT06630923 ·Status: RECRUITING ·Phase: PHASE3
-
Safety and Performance Evaluation of the Nephronyx System for the Treatment of Patients With ADHF
NCT05759806 ·Status: RECRUITING ·Phase: NA
-
Mechanisms of Diuretic Resistance in Heart Failure, Aim 3
NCT06209359 ·Status: RECRUITING ·Phase: PHASE1
-
Natriuresis-Guided Diuretic Therapy in Patients With Acute Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease
NCT06203236 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Significance of Regional Ventriculo-arterial Coupling in Patients With Chronic Heart Failure
NCT01298258 ·Status: UNKNOWN ·Phase: NA
-
Use of Nesiritide (BNP) in Kidney Function in Patients With Congestive Heart Failure (CHF) and Kidney Failure
NCT00348556 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Ultrasound Guided Diuretic Therapy in Type 1 Cardiorenal Syndrome
NCT06065163 ·Status: UNKNOWN ·Phase: NA
-
Effect of Renin Angiotensin Aldosterone System Genetic Polymorphism on the Pharmacological Effect of Mineralocorticoid Receptor Antagonists in Patients With Myocardial Infarction
NCT05873400 ·Status: UNKNOWN
-
Intra-Renal Therapy of Diuretic Unresponsive Acute Kidney Injury
NCT01073189 ·Status: WITHDRAWN ·Phase: PHASE4
-
Increased Activity of a Renal Salt Transporter (ENaC) in Diabetic Kidney Disease
NCT01918488 ·Status: UNKNOWN ·Phase: NA
-
Mechanism(s) Underlying Cardiovascular Effects of ARB/NEP Inhibition - Aim 2
NCT03005184 ·Status: WITHDRAWN ·Phase: PHASE2
-
Measurement of Sweat Sodium Concentration in Patients With Chronic Kidney Disease
NCT06354842 ·Status: COMPLETED
-
Mechanisms of Diuretic Resistance in Heart Failure, Aim 2
NCT05753059 ·Status: RECRUITING ·Phase: PHASE1
-
Vascular Effects of Mineralocorticoid Receptor Antagonism in Kidney Disease
NCT02497300 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
NCT00920764 ·Status: COMPLETED ·Phase: PHASE2